Pfizer (BOG:PFECO) Cyclically Adjusted FCF per Share: COP0.00 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOG:PFECO Pfizer Inc BOG:PFECO
70 GF Score
Price COP95,840.00
GF Value COP99,518.78
! 5 Warning Signs
View Full Analysis

What is Pfizer Cyclically Adjusted FCF per Share?

Pfizer BOG:PFECO 70 Cyclically Adjusted FCF per Share is COP0.00 as of Mar. 2026. GuruFocus rates BOG:PFECO with a GF Score™ of 70/100 and a GF Value™ of COP99,518.78. The stock has 5 warning signs investors should review.

Note: As Cyclically Adjusted FCF per Share is a main component used to calculate Cyclically Adjusted Price-to-FCF. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Pfizer's adjusted free cash flow per share for the three months ended in Mar. 2026 was COP1,397.373. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is COP0.00 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Pfizer's average Cyclically Adjusted FCF Growth Rate was -1.60% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -2.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 3.50% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 4.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Pfizer was 29.20% per year. The lowest was -2.40% per year. And the median was 8.50% per year.

As of today (2026-08-01), Pfizer's current stock price is COP95840.00. Pfizer's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was COP0.00. Pfizer's Cyclically Adjusted Price-to-FCF of today is .

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pfizer was 21.47. The lowest was 7.09. And the median was 14.27.


Pfizer  (BOG:PFECO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Pfizer was 21.47. The lowest was 7.09. And the median was 14.27.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Pfizer Cyclically Adjusted FCF per Share Related Terms


Pfizer Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Pfizer's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Cyclically Adjusted FCF per Share Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

BOG:PFECO vs BMY, GILD, AMGN: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Pfizer's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pfizer Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Pfizer's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Pfizer's Cyclically Adjusted Price-to-FCF falls into.


BOG:PFECO
70GF Score
Pfizer Inc BOG:PFECO
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pfizer's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1397.373/330.2130*330.2130
=1,397.373

Current CPI (Mar. 2026) = 330.2130.

Pfizer Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 1,573.460 241.018 2,155.760
201609 2,040.570 241.428 2,790.988
201612 2,650.882 241.432 3,625.682
201703 580.565 243.801 786.338
201706 1,387.302 244.955 1,870.160
201709 2,090.234 246.819 2,796.472
201712 3,141.087 246.524 4,207.411
201803 743.356 249.554 983.618
201806 1,661.178 251.989 2,176.851
201809 2,389.538 252.439 3,125.731
201812 2,188.940 251.233 2,877.076
201903 578.373 254.202 751.317
201906 1,203.385 256.143 1,551.373
201909 2,310.571 256.759 2,971.583
201912 2,239.342 256.974 2,877.567
202003 1,673.734 258.115 2,141.250
202006 2,054.307 257.797 2,631.368
202009 1,038.308 260.280 1,317.284
202012 3,028.916 260.474 3,839.874
202103 2,551.927 264.877 3,181.399
202106 6,963.269 271.696 8,462.995
202109 6,696.739 274.310 8,061.501
202112 3,356.307 278.802 3,975.209
202203 4,021.374 287.504 4,618.753
202206 4,898.267 296.311 5,458.695
202209 3,979.422 296.808 4,427.296
202212 6,293.537 296.797 7,002.118
202303 61.615 301.836 67.408
202306 -1,647.040 305.109 -1,782.556
202309 1,900.321 307.789 2,038.769
202312 2,951.592 306.746 3,177.398
202403 265.986 312.332 281.214
202406 -1,636.098 314.175 -1,719.618
202409 4,438.308 315.301 4,648.216
202412 4,512.404 315.605 4,721.264
202503 1,279.657 319.799 1,321.328
202506 -848.673 322.561 -868.806
202509 2,744.123 324.800 2,789.856
202512 2,943.602 324.054 2,999.548
202603 1,397.373 330.213 1,397.373

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of COP0.00 mean?
Pfizer (BOG:PFECO) has a Cyclically Adjusted FCF per Share of COP0.00 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pfizer and its competitors.
Is Pfizer's Cyclically Adjusted FCF per Share too high?
Pfizer's current Cyclically Adjusted FCF per Share is COP0.00. Overall, Pfizer has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Cyclically Adjusted FCF per Share compare to BMY and GILD?
Pfizer's Cyclically Adjusted FCF per Share of COP0.00 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Pfizer and its competitors. Pfizer's current Cyclically Adjusted FCF per Share is COP0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Pfizer (BOG:PFECO) has a current Cyclically Adjusted FCF per Share of COP0.00. The stock's GF Value™ is COP99,518.78, compared to a current price of COP95,840.00 — trading 3.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is COP0.00. Pfizer's overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Pfizer (BOG:PFECO), the current Cyclically Adjusted FCF per Share is COP0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (BOG:PFECO) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of COP95,840.00 is trading 3.7% below its estimated GF Value™ of COP99,518.78.

Key valuation signals for BOG:PFECO:

  • Cyclically Adjusted FCF per Share: COP0.00
  • GF Value™: COP99,518.78 vs. price of COP95,840.00 (3.7% below fair value)
  • GF Score™: 70/100 with 5 warning signs

No single metric tells the full story. See the BOG:PFECO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
70GF Score

Get the complete analysis for BOG:PFECO

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

COP95,840.00
Price
COP99,518.78
GF Value